Ranking · Trials
Active Phase III trials
Active interventional studies with PHASE3 among their phases, mapped to this cancer or its descendants.
Computedci-phase3-trials-v1unit: counthigher = betterAll metrics
| Rank | Δ | Cancer | Active Phase III trials (count) | Percentile | Confidence | Sources | Why #n? |
|---|---|---|---|---|---|---|---|
| 1 | = | Malignant Lung Neoplasm | 382 | 100 | Medium confidence | clinicaltrials | inputs
ranking row 2580726 |
| 2 | = | Malignant Breast Neoplasm | 320 | 97.1 | Medium confidence | clinicaltrials | inputs
ranking row 2580727 |
| 3 | = | Non-Hodgkin Lymphoma | 252 | 94.3 | Medium confidence | clinicaltrials | inputs
ranking row 2580728 |
| 4 | = | Leukemia | 190 | 91.4 | Medium confidence | clinicaltrials | inputs
ranking row 2580729 |
| 5 | = | Malignant Prostate Neoplasm | 148 | 88.6 | Medium confidence | clinicaltrials | inputs
ranking row 2580730 |
| 6 | = | Multiple Myeloma | 115 | 85.7 | Medium confidence | clinicaltrials | inputs
ranking row 2580731 |
| 7 | = | Malignant Nasopharyngeal Neoplasm | 97 | 82.9 | Medium confidence | clinicaltrials | inputs
ranking row 2580732 |
| 8 | = | Malignant Liver Neoplasm | 94 | 80 | Medium confidence | clinicaltrials | inputs
ranking row 2580733 |
| 9 | = | Malignant Ovarian Neoplasm | 89 | 77.1 | Medium confidence | clinicaltrials | inputs
ranking row 2580734 |
| 10 | = | Malignant Gastric Neoplasm | 78 | 74.3 | Medium confidence | clinicaltrials | inputs
ranking row 2580735 |
| 11 | = | Malignant Esophageal Neoplasm | 69 | 71.4 | Medium confidence | clinicaltrials | inputs
ranking row 2580736 |
| 11 | = | Malignant Pancreatic Neoplasm | 69 | 71.4 | Medium confidence | clinicaltrials | inputs
ranking row 2580737 |
| 13 | = | Malignant Cervical Neoplasm | 59 | 65.7 | Medium confidence | clinicaltrials | inputs
ranking row 2580738 |
| 14 | = | Malignant Rectal Neoplasm | 57 | 62.9 | Medium confidence | clinicaltrials | inputs
ranking row 2580739 |
| 15 | = | Malignant Bladder Neoplasm | 48 | 60 | Medium confidence | clinicaltrials | inputs
ranking row 2580740 |
| 16 | = | Malignant Central Nervous System Neoplasm | 47 | 57.1 | Medium confidence | clinicaltrials | inputs
ranking row 2580741 |
| 17 | = | Malignant Kidney Neoplasm | 46 | 54.3 | Medium confidence | clinicaltrials | inputs
ranking row 2580742 |
| 18 | = | Malignant Uterine Corpus Neoplasm | 41 | 51.4 | Medium confidence | clinicaltrials | inputs
ranking row 2580743 |
| 19 | = | Malignant Colon Neoplasm | 32 | 48.6 | Medium confidence | clinicaltrials | inputs
ranking row 2580744 |
| 20 | = | Malignant Lip and Oral Cavity Neoplasm | 17 | 45.7 | Medium confidence | clinicaltrials | inputs
ranking row 2580745 |
| 21 | = | Malignant Oropharyngeal Neoplasm | 15 | 42.9 | Medium confidence | clinicaltrials | inputs
ranking row 2580747 |
| 21 | = | Malignant Thyroid Gland Neoplasm | 15 | 42.9 | Medium confidence | clinicaltrials | inputs
ranking row 2580746 |
| 23 | = | Skin Carcinoma | 14 | 37.1 | Medium confidence | clinicaltrials | inputs
ranking row 2580748 |
| 24 | = | Hodgkin Lymphoma | 12 | 34.3 | Medium confidence | clinicaltrials | inputs
ranking row 2580749 |
| 25 | = | Malignant Hypopharyngeal Neoplasm | 9 | 31.4 | Medium confidence | clinicaltrials | inputs
ranking row 2580751 |
| 25 | = | Malignant Laryngeal Neoplasm | 9 | 31.4 | Medium confidence | clinicaltrials | inputs
ranking row 2580750 |
| 27 | = | Malignant Anal Neoplasm | 7 | 25.7 | Medium confidence | clinicaltrials | inputs
ranking row 2580752 |
| 28 | = | Cutaneous Melanoma | 6 | 22.9 | Medium confidence | clinicaltrials | inputs
ranking row 2580753 |
| 29 | = | Malignant Gallbladder Neoplasm | 3 | 20 | Medium confidence | clinicaltrials | inputs
ranking row 2580754 |
| 29 | = | Malignant Testicular Neoplasm | 3 | 20 | Medium confidence | clinicaltrials | inputs
ranking row 2580755 |
| 29 | = | Malignant Vaginal Neoplasm | 3 | 20 | Medium confidence | clinicaltrials | inputs
ranking row 2580756 |
| 32 | = | Malignant Mesothelioma | 2 | 11.4 | Medium confidence | clinicaltrials | inputs
ranking row 2580757 |
| 32 | = | Malignant Penile Neoplasm | 2 | 11.4 | Medium confidence | clinicaltrials | inputs
ranking row 2580759 |
| 32 | = | Malignant Salivary Gland Neoplasm | 2 | 11.4 | Medium confidence | clinicaltrials | inputs
ranking row 2580758 |
| 32 | = | Malignant Vulvar Neoplasm | 2 | 11.4 | Medium confidence | clinicaltrials | inputs
ranking row 2580760 |
| 36 | = | Kaposi Sarcoma | 1 | 0 | Medium confidence | clinicaltrials | inputs
ranking row 2580761 |
Data updated 16 hours agoSource updated unknown36 eligible entities · inputs hash 7e874e202ec3e68f4c4a2534